Benign Prostatic Hyperplasia News and Research

RSS

MRI-guided ultrasound ablation: safer better treatment for prostate cancer

Prostate cancer may soon be treated more effectively using ultrasound at therapeutic levels, without the significant and distressing side effects of more traditional treatments. A new study presented on December 2, 2019, presents the outcome of using focused ultrasound ablation under MRI guidance in a novel procedure that can be used to treat both benign and malignant enlargement of the prostate gland.

2 Dec 2019

UCLA researchers discover link between progenitor cells and age-related prostate growth

The prostates of older mice contain more luminal progenitor cells -- cells capable of generating new prostate tissue -- than the prostates of younger mice, UCLA researchers have discovered.

6 Aug 2019

A 'health number' that could tell about prostate disease

When it comes to staying on top of your health, doctors often tell you how important it is to "know your numbers." Blood pressure, cholesterol and body mass index can tell you a lot about your heart health, but if you're a man, you need to know one more - your PSA, or prostate-specific antigen.

18 Jun 2019

Scientists identify two genes that may play a role in prostate enlargement

For aging men, prostate enlargement is almost as common as graying hair, and yet scientists know very little about why the prostate increases in size or how the process occurs on a molecular level.

17 Jun 2019

Prostate drugs linked to increased risk of developing type 2 diabetes

Researchers say patients should continue to take the drugs, which are commonly prescribed to older men, but warn they may need additional health checks.

11 Apr 2019

New study shows that larger prostate actually impedes tumor growth

For men older than about 60, an enlarged prostate means feeling the urge to make a pit stop way too often throughout the day.

5 Feb 2019

NeoTract presents new clinical data from studies of UroLift System for patients with BPH

NeoTract, a wholly owned subsidiary of Teleflex Incorporated focused on addressing unmet needs in the field of urology, today announced the presentation of new clinical data at the World Congress of Endourology 2018 Annual Conference from two U.K. studies of the company's novel UroLift System for patients with Benign Prostatic Hyperplasia.

25 Sep 2018

Pioneering procedure for common prostate condition offered by The London Clinic

The London Clinic is one of the first hospitals in the UK to offer prostate artery embolization, a new procedure for non-cancerous enlargement of the prostate, a very common condition in older men.

24 Sep 2018

Study: Social disparities linked with higher prevalence of benign prostatic hyperplasia

In an Andrologia study of 100,000 men in Korea, social disparities--such as low education level and low household income, current or previous use of medical aid health insurance, blue-collar employment or unemployment, divorce, and low social capital of communities--were all linked with a higher prevalence of benign prostatic hyperplasia, a condition that is characterized by an enlarged prostate due to aging, lower urinary tract blockage, and other factors.

22 Aug 2018

UC San Diego Health now offers new treatment option for men with enlarged prostate

Physicians at UC San Diego Health are now offering prostate artery embolization as a new treatment option for men with benign prostatic hyperplasia, or an enlarged prostate.

10 Jul 2018

NeoTract announces results of study measuring costs and patient outcomes of UroLift System

NeoTract, a wholly owned subsidiary of Teleflex Incorporated focused on addressing unmet needs in the field of urology, today announced the results of an independent analysis measuring costs and patient outcomes of the UroLift System compared to transurethral resection of the prostate.

8 Jun 2018

AUA recommends use of UroLift System for managing lower urinary tract symptoms attributed to BPH

NeoTract, a wholly owned subsidiary of Teleflex Incorporated focused on addressing unmet needs in the field of urology, today announced that the American Urological Association has recommended the use of the UroLift System as a standard of care treatment for lower urinary tract symptoms due to benign prostatic hyperplasia.

18 May 2018

Common factors that could change your PSA test results

Most men in their 50s, who face an increasing risk of prostate cancer as they age, are familiar with the common screening exam known as the prostate specific antigen (PSA) test. But many are less familiar with how the test works and why different factors, such as prescription medications and infections, can influence the test results.

28 Oct 2017

UTSA professor awarded grant to support development of prostate cancer detection method

Jing Yong Ye, professor of biomedical engineering at The University of Texas at San Antonio (UTSA), has received a two-year, $354,617 grant from the National Institutes of Health's National Cancer Institute to support the development of his noninvasive method of detecting prostate cancer.

25 Sep 2017

Popular prostate drug has negative impact on men's overall health, study suggests

Treatment of benign prostatic hyperplasia (BPH) with the commonly prescribed Avodart (Dutsteride) may put men at an increased risk for diabetes, elevated cholesterol levels, non-alcoholic fatty liver disease (NAFLD) and worsening erectile dysfunction.

22 Jun 2017

Use of 5ARIs for prostatic enlargement not linked to increased suicide risk in older men

Using 5α- reductase inhibitors was not associated with increased suicide risk in a group of older men but risks for self-harm and depression were increased during the 18 months after medication initiation, although "the relatively small magnitude of these risks should not dissuade physicians from prescribing these medications in appropriate patients," according to an article published online by JAMA Internal Medicine.

20 Mar 2017

Remnant fetal tissue could contribute to enlarged prostate in later life

New research from Michigan State University indicates that embryonic tissue, key to the development of a baby's gender, could contribute to an enlarged prostate, or BPH, in men later in life.

14 Mar 2017

Shape of prostate and compartments in gland differ in men with cancer, research reveals

Preliminary computerized imaging reveals the shape of the prostate and a compartment within the gland--called the transitional zone--consistently differ in men with prostate cancer than those without the disease, according to new research led by Case Western Reserve University.

1 Feb 2017

PITX2 methylation biomarker shows promise for predicting prostate cancer recurrence risk

Prostate-specific antigen (PSA) and other biomarkers are essential tools for diagnosing and monitoring prostate cancer.

8 Dec 2016

Erectile dysfunction drugs do not play role in preventing prostate cancer, study shows

While some previous studies have indicated that taking erectile dysfunction (ED) drugs may reduce the likelihood of developing prostate cancer, new research published in The Journal of Urology found that these drugs do not play a role in preventing prostate cancer.

2 Aug 2016